Patent · US Active

Substituted nucleosides, nucleotides and analogs thereof

US10793591B2 · kind B2 · utility

2Cited by

47References

6Claims

0Family size

Assignee

Janssen BioPharma, Inc. · US

Inventors

Leonid Beigelman · San Mateo, US
Guangyi Wang · Carlsbad, US
David Bernard Smith · San Mateo, US

Key dates

Filing date	Nov 22, 2019
Grant date	Oct 6, 2020
Priority date	—
Expiry date	Nov 22, 2039

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/213
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.